Archive: 06/09/2017

Danish drugmaker reaches settlement with US authorities

Danish drug maker Novo Nordisk says it has reached a $46.5 million settlement with U.S. authorities over allegations that it hadn't properly communicated safety information when marketing a medicine to treat type 2 diabetes.

page 8 from 9